アイオワ州における乳がんの臨床試験
アイオワ州内の拠点で、乳がんに関する22件の研究が参加者を募集しています。
アイオワ州内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他12件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Accellacare of McFarland, Ames
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07102381Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Des Moines
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- Local Institution - 0065, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06618287A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- University of Iowa, Iowa City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Mission Cancer and Blood, Des Moines
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
- University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06756932Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他17件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- University of Iowa, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399Exercise Oncology Clinic Pilot Feasibility Trial
- University of Iowa Health Care, Iowa City
被験者募集中
18歳以上 · 全性別 · 2026/08/14更新 · NCT07765927Breast Cancer PSMA PET
- University of Iowa Healthcare, Iowa City
被験者募集中早期第1相
18歳〜90歳 · 女性 · 2026/08/06更新 · NCT06586047E-Mindfulness Approaches for Living After Breast Cancer
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Saint Anthony Regional Hospital, Carroll
- 他10件
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- University of Iowa, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
- Iowa Holden Comprehensive Cancer Center, Iowa City
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/07更新 · NCT06169371Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05283330De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他11件
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887Quantitative MRI Assessment of Breast Cancer Therapy Response
- University of Iowa, Iowa City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/17更新 · NCT05704062Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Physicians' Clinic of Iowa PC, Cedar Rapids
- 他10件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Medical Oncology and Hematology Associates-West Des Moines, Clive
- Mercy Cancer Center-West Lakes, Clive
- Mercy Medical Center - Des Moines, Des Moines
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。